Stealth BioTherapeutics Corp (MITO) Ownership

0.32 ↑0.00 (1.38%)

As of November 15, 2022, 3:57pm EST.

Institutions
Mutual Funds

Institutional Ownership

Ikarian Capital, LLC is the biggest individual institutional holder of Stealth BioTherapeutics Corp (MITO), owning a total of 436 thousand shares. Combined, the top 21 institutional holders of MITO own 1.27% of the company with a total of 0.9 million shares.

In the latest ownership report on September 30th 2022, the top 21 institutional holders decreased their combined ownership of MITO by 360 thousand shares. 4 institutions bought 88,535 total additional shares and increased their ownership by an average of 147.89%. However 9 institutions sold 448,158 total shares and decreased their ownership by an average of 64.06%.

Overall this is a negative sign as the number of shares owned by the top 20 institutional holders of Stealth BioTherapeutics Corp decreased by a net total of -359,623 in the latest quarter.

Institution Ownership Chart

Latest Institutional Ownership Changes

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
Ikarian Capital, LLC	0.592%	-13.216%	435,516	-66,320	2022-09-30
Brown Brothers Harriman & Co	0.238%	0.000%	174,999	0	2022-09-30
Renaissance Technologies Corp	0.132%	556.402%	96,944	82,175	2022-09-30
Geode Capital Management, LLC	0.066%	0.000%	48,791	0	2022-09-30
BOOTHBAY FUND MANAGEMENT, LLC	0.060%	-9.519%	43,790	-4,607	2022-09-30
Susquehanna International Group, LLP	0.042%	-42.794%	30,991	-23,183	2022-09-30
Envestnet Asset Management Inc	0.032%	30.285%	23,248	5,404	2022-09-30
CapTrust Financial Advisors	0.020%	0.000%	15,000	0	2022-09-30
Two Sigma Advisers, LLC	0.019%	-11.039%	13,700	-1,700	2022-09-30
Advisor Group Holdings, Inc.	0.014%	4.858%	10,124	469	2022-09-30
AlphaMark Advisors, LLC	0.003%	0.000%	2,306	0	2022-09-30
UBS Group AG	0.001%	0.000%	487	487	2022-09-30
Millennium Management LLC	0.000%	-100.000%	0	-41,517	2022-09-30
HighTower Advisors, LLC	0.000%	-100.000%	0	-56,000	2022-09-30
Two Sigma Investments LLC	0.000%	-100.000%	0	-13,314	2022-09-30
Citadel Advisors Llc	0.000%	-100.000%	0	-141,226	2022-09-30
Virtu Financial LLC	0.000%	-100.000%	0	-100,291	2022-09-30

Top Institutions

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
Ikarian Capital, LLC	0.592%	-13.216%	435,516	-66,320	2022-09-30
Brown Brothers Harriman & Co	0.238%	0.000%	174,999	0	2022-09-30
Renaissance Technologies Corp	0.132%	556.402%	96,944	82,175	2022-09-30
Geode Capital Management, LLC	0.066%	0.000%	48,791	0	2022-09-30
BOOTHBAY FUND MANAGEMENT, LLC	0.060%	-9.519%	43,790	-4,607	2022-09-30
HRT FINANCIAL LLC	0.049%	0.000%	36,342	36,342	2022-06-30
Susquehanna International Group, LLP	0.042%	-42.794%	30,991	-23,183	2022-09-30
Envestnet Asset Management Inc	0.032%	30.285%	23,248	5,404	2022-09-30
CapTrust Financial Advisors	0.020%	0.000%	15,000	0	2022-09-30
Two Sigma Advisers, LLC	0.019%	-11.039%	13,700	-1,700	2022-09-30
Advisor Group Holdings, Inc.	0.014%	4.858%	10,124	469	2022-09-30
Urban Wealth Management, LLC	0.004%	0.000%	2,939	2,939	2022-06-30
AlphaMark Advisors, LLC	0.003%	0.000%	2,306	0	2022-09-30
UBS Group AG	0.001%	0.000%	487	487	2022-09-30
Morgan Stanley - Brokerage Accounts	0.000%	-100.000%	0	-5,000	2022-06-30
Millennium Management LLC	0.000%	-100.000%	0	-41,517	2022-09-30
HighTower Advisors, LLC	0.000%	-100.000%	0	-56,000	2022-09-30
Citigroup Inc	0.000%	-100.000%	0	-6,000	2022-06-30
Two Sigma Investments LLC	0.000%	-100.000%	0	-13,314	2022-09-30
Citadel Advisors Llc	0.000%	-100.000%	0	-141,226	2022-09-30
Virtu Financial LLC	0.000%	-100.000%	0	-100,291	2022-09-30

Mutual Fund Ownership

Fidelity® NASDAQ Composite Index® is the biggest individual fund holder of Stealth BioTherapeutics Corp (MITO), owning a total of 49 thousand shares. Combined, the top 1 mutual fund holders of MITO own 0.07% of the company with a total of 49 thousand shares.

In the latest ownership report on October 31st 2022, the top 1 fund holders not made any changes to their ownership of MITO. None of the mutual funds bought any additional shares.

Overall this is a neutral sign as the number of shares owned by the top 20 mutual funds holding Stealth BioTherapeutics Corp stayed the same in the latest report.